- Health
- Viruses, Infections & Disease
- Cancer
A clinical trial shows that AI-assisted mammography can detect more cases of dangerous cancer and reduce missed diagnoses.
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.
A clinical trial suggests that an AI trained to look for signs of breast cancer can help radiologists spot more cancers, earlier, compared to unassisted radiologists.
(Image credit: Getty Images)
- Copy link
- X
Get the world’s most fascinating discoveries delivered straight to your inbox.
Become a Member in Seconds
Unlock instant access to exclusive member features.
Contact me with news and offers from other Future brands Receive email from us on behalf of our trusted partners or sponsors By submitting your information you agree to the Terms & Conditions and Privacy Policy and are aged 16 or over.You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Signup +
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Signup +
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Signup +
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Signup +
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Signup +
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Signup +Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
Explore An account already exists for this email address, please log in. Subscribe to our newsletterA first-of-its-kind trial demonstrates that AI-assisted mammography can improve the outcomes of patients with breast cancer, particularly those with aggressive disease.
While many people have only recently begun to use artificial intelligence (AI) in their everyday lives, the technology's use in medicine began about a decade ago, especially in the field of image-based diagnostics. Researchers have been training AI programs to recognize tumors and other signs of disease in various medical imagery, such as X-rays, MRIs, and tissue biopsies mounted on slides.
You may like-
Can AI detect cognitive decline better than a doctor? New study reveals surprising accuracy
-
New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?
-
AI is getting better and better at generating faces — but you can train to spot the fakes
However, to know if an AI tool can really diagnose cancer and make a difference to patients, you need to have a "prospective" study — one in which patients who are diagnosed using the AI tool are then followed for several years to determine their health outcomes.
Now, researchers in Sweden have conducted a gold-standard trial to assess the use of AI in mammography screening. Results from the Mammography Screening with Artificial Intelligence (MASAI) trial, published Jan. 31 in the journal The Lancet, showed that mammography reading supported by AI can improve screening performance while reducing radiologists' workload.
This is the first time AI has been shown to improve the outcomes of patients with breast cancer.
Spotting cancer earlier
The practice of regularly screening patients has significantly reduced the incidence of late-stage cancer and breast cancer deaths in much of the world. But even with regular mammograms, some cancer may go undetected.
Sign up for the Live Science daily newsletter nowContact me with news and offers from other Future brandsReceive email from us on behalf of our trusted partners or sponsorsBy submitting your information you agree to the Terms & Conditions and Privacy Policy and are aged 16 or over.These "interval cancers" are not detected at an initial screening but get diagnosed within the next two years, or between two screening rounds. They are often missed because they are masked during the initial screen due to breast-tissue density or the tumor disguising itself as normal tissue. Or sometimes, they can develop very quickly between screening dates.
These cancers are invasive, spreading into nearby healthy tissues, and typically aggressive, resulting in worse patient outcomes. Declines in interval cancer rates are the best way to confirm that a screening method works, meaning it drives down late-stage cancer diagnoses by spotting more cases earlier.
"If you want to improve the efficacy of screening, then the interval cancer rate is a very good surrogate measure of breast cancer mortality," senior study author Dr. Kristina Lång, a breast radiologist and clinical researcher at Lund University in Sweden, told Live Science. "So if we can lower the interval cancers, it will likely have a positive impact on patient outcomes."
You may like-
Can AI detect cognitive decline better than a doctor? New study reveals surprising accuracy
-
AI is getting better and better at generating faces — but you can train to spot the fakes
-
AI may accelerate scientific progress — but here's why it can't replace human scientists
The MASAI trial included more than 100,000 women between the ages of 40 and 80 living in Sweden. It used a commercially available AI system that was trained on more than 200,000 examinations from medical institutions all over the world.
In a comparison group, mammograms were read by two radiologists, as is the standard in Sweden. In the AI-assisted group, the AI system analyzed mammograms for suspicious findings and provided a risk score of 1 to 10. Cases with a score of 1 to 9 were subsequently read by a single radiologist, while a score of 10 would be read by two radiologists. The AI system was also able to highlight the suspicious findings within the image so the human radiologists could easily review them.
The AI-supported screening identified more clinically relevant cancers than unassisted mammography did. "Clinically relevant" cancers are those that have the potential to progress and thus require medical intervention.
It also reduced the number of interval cancer diagnoses within the two years following the screen. This shows that the AI program was more effective at identifying cancers that might normally be missed by a human radiologist, allowing medical treatments to start earlier.
Reducing false positives
While cancer screening is mostly beneficial, there are some potential downsides, such as false positives and overdiagnosis. When a patient is called back for a recheck after a screening but does not have cancer, "that can be a really stressful experience," Lång said.
The latter situation, overdiagnosis, refers to situations where a screen detects a cancer that will ultimately cause no harm to the patient. Such cancers grow so slowly that they won't cause symptoms within a patient's lifetime or increase the chance of death. Overdiagnosis can subject healthy patients to unnecessary cancer treatments.
The goal of AI-assisted mammography is to improve the ability of the screening test to find cancer while mitigating these potential negative effects — and the study found that AI-assisted screening did not increase the risk of false positives and that it improved the detection of clinically relevant cancers.
Along with improving cancer detection, AI-assisted screenings could address the consistent shortage of radiologists available to provide cancer screening.
"In some places, you're lucky to find one radiologist to read the mammograms," said Dr. Richard Wahl, a radiation oncologist at Washington University in St. Louis who was not involved in the study. "If you don't have the expert radiologists, women can't benefit like they should from screening programs."
RELATED STORIES—New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?
—It matters what time of day you get cancer treatment, study suggests
—New triple-drug treatment stops pancreatic cancer in its tracks, a mouse study finds
Additionally, as the few radiologists available work more hours, their performance decreases. But AI doesn't get tired, and its performance doesn't decline at the end of the workday.
"The workforce issue is real, and this [study] could have an impact," Wahl said. "I think people will gradually be interested in having AI-aided interpretation as a second set of eyes."
Lång and her team will be starting a screening trial in Ethiopia in March, during which they will use AI to support the rapid assessment of breast cancer using bedside ultrasounds within a screening program.
"The problem in these settings where they don't have a screening program is that many women come in with late-stage disease, and there are no radiologists there," Lång said. With AI support, Lång hopes to improve access to accurate screening and thus enable earlier diagnosis of breast cancer in these limited resource settings.
DisclaimerThis article is for informational purposes only and is not meant to offer medical advice.
Article SourcesGommers, J., et al. (2026). Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the Masai study: A randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial. The Lancet, 407(10527), 505–514. https://doi.org/10.1016/s0140-6736(25)02464-x
Jennifer ZiebaLive Science ContributorJennifer Zieba earned her PhD in human genetics at the University of California, Los Angeles. She is currently a project scientist in the orthopedic surgery department at UCLA where she works on identifying mutations and possible treatments for rare genetic musculoskeletal disorders. Jen enjoys teaching and communicating complex scientific concepts to a wide audience and is a freelance writer for multiple online publications.
View MoreYou must confirm your public display name before commenting
Please logout and then login again, you will then be prompted to enter your display name.
Logout Read more
Can AI detect cognitive decline better than a doctor? New study reveals surprising accuracy
AI is getting better and better at generating faces — but you can train to spot the fakes
AI may accelerate scientific progress — but here's why it can't replace human scientists
Scientists are developing a 'self-driving' device that helps patients recover from heart attacks
Even AI has trouble figuring out if text was written by AI — here's why
Giving AI the ability to monitor its own thought process could help it think like humans
Latest in Cancer
New triple-drug treatment stops pancreatic cancer in its tracks, a mouse study finds
Color blindness linked to lower bladder cancer survival, early study hints
It matters what time of day you get cancer treatment, study suggests
Widespread cold virus you've never heard of may play key role in bladder cancer
New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?
Science history: Female chemist initially barred from research helps develop drug for remarkable-but-short-lived recovery in children with leukemia — Dec. 6, 1954
Latest in News
'There's no reason to ban us from playing': Analysis debunks notion that transgender women have inherent physical advantages in sports
'Invisible scaffolding of the universe' revealed in ambitious new James Webb telescope images
AI-supported breast cancer screening spots more cancers earlier, landmark trial finds
Extraordinary photo captures first appearance of Siberian peregrine falcon in Australia's arid center
Scientist accidentally stumbles across bizarre ancient ‘wrinkle structures’ in Morocco that shouldn't be there
Discoveries inside Earth, Artemis II scrub, and an ape that can play pretend
LATEST ARTICLES- 1'There's no reason to ban us from playing': Analysis debunks notion that transgender women have inherent physical advantages in sports
- 2Clean energy is surging — with or without Trump
- 3Top 5 tips for buying an electric toothbrush for kids, according to experts
- 4Science news this week: Anomalies inside Earth, leak on Artemis II, and how psychedelics may help treat PTSD
- 5Why do kids eat their boogers?
